CymaBay Therapeutics, Inc.

Tower Research Capital LLC (TRC)

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/13/2024

Shares

10,517

Value ($000)

248

Weight

0.0%

2020 Q1 - 2023 Q4 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/13/2024	248	0.0%	10,517	12/31/2023
2023 Q3	11/14/2023	28	0.0%	1,881	9/30/2023
2023 Q2	8/14/2023	283	0.0%	25,879	6/30/2023
2023 Q1	5/9/2023	16	0.0%	1,828	3/31/2023
2022 Q4	2/10/2023	13	0.0%	2,057	12/31/2022
2022 Q3	11/10/2022	23	0.0%	6,527	9/30/2022
2022 Q2	8/15/2022	36	0.0%	12,386	6/30/2022
2022 Q1	5/12/2022	82	0.0%	26,382	3/31/2022
2021 Q4	2/14/2022	16	0.0%	4,593	12/31/2021
2021 Q3	11/15/2021	46	0.0%	12,645	9/30/2021
2021 Q2	8/16/2021	85	0.0%	19,475	6/30/2021
2021 Q1	5/17/2021	29	0.0%	6,459	3/31/2021
2020 Q4	2/16/2021	95	0.0%	16,686	12/31/2020
2020 Q3	11/16/2020	545	0.0%	75,209	9/30/2020
2020 Q2	8/13/2020	52	0.0%	14,855	6/30/2020
2020 Q1	5/15/2020	8	0.0%	5,528	3/31/2020